메뉴 건너뛰기




Volumn 114, Issue 11, 2014, Pages 1700-1712

Sorafenib cardiotoxicity increases mortality after myocardial infarction

Author keywords

cell death; metoprolol; myocardial infarction; sorafenib; stem cells

Indexed keywords

BROXURIDINE; METOPROLOL; SORAFENIB;

EID: 84901611229     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.114.303200     Document Type: Article
Times cited : (73)

References (63)
  • 1
    • 57749188299 scopus 로고    scopus 로고
    • Targeting cancer with small molecule kinase inhibitors
    • Zhang J, Yang PL, Gray NS. Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer. 2009;9:28-39.
    • (2009) Nat Rev Cancer , vol.9 , pp. 28-39
    • Zhang, J.1    Yang, P.L.2    Gray, N.S.3
  • 2
    • 34247480545 scopus 로고    scopus 로고
    • Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition
    • Force T, Krause DS, Van Etten RA. Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition. Nat Rev Cancer 2007;7:332-344.
    • (2007) Nat Rev Cancer , vol.7 , pp. 332-344
    • Force, T.1    Krause, D.S.2    Van Etten, R.A.3
  • 3
    • 33746845181 scopus 로고    scopus 로고
    • Cardiotoxicity of the cancer therapeutic agent imatinib mesylate
    • Kerkelä R, Grazette L, Yacobi R, et al. Cardiotoxicity of the cancer therapeutic agent imatinib mesylate. Nat Med. 2006;12:908-916.
    • (2006) Nat Med. , vol.12 , pp. 908-916
    • Kerkelä, R.1    Grazette, L.2    Yacobi, R.3
  • 4
    • 80054003549 scopus 로고    scopus 로고
    • Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: Focus on hypertension
    • Nazer B, Humphreys BD, Moslehi J. Effects of novel angiogenesis inhibitors for the treatment of cancer on the cardiovascular system: focus on hypertension. Circulation 2011;124:1687-1691.
    • (2011) Circulation , vol.124 , pp. 1687-1691
    • Nazer, B.1    Humphreys, B.D.2    Moslehi, J.3
  • 5
    • 36849023013 scopus 로고    scopus 로고
    • Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib
    • Chu TF, Rupnick MA, Kerkela R, et al. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib. Lancet 2007;370:2011-2019.
    • (2007) Lancet , vol.370 , pp. 2011-2019
    • Chu, T.F.1    Rupnick, M.A.2    Kerkela, R.3
  • 10
    • 0027242125 scopus 로고
    • Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase-kinase
    • Kyriakis JM, Force TL, Rapp UR, Bonventre JV, Avruch J. Mitogen regulation of c-Raf-1 protein kinase activity toward mitogen-activated protein kinase-kinase. J Biol Chem. 1993;268:16009-16019.
    • (1993) J Biol Chem. , vol.268 , pp. 16009-16019
    • Kyriakis, J.M.1    Force, T.L.2    Rapp, U.R.3    Bonventre, J.V.4    Avruch, J.5
  • 16
    • 36749098486 scopus 로고    scopus 로고
    • Bone marrow cells adopt the cardiomyogenic fate in vivo
    • Rota M, Kajstura J, Hosoda T, et al. Bone marrow cells adopt the cardiomyogenic fate in vivo. Proc Natl Acad Sci USA. 2007;104:17783-17788.
    • (2007) Proc Natl Acad Sci USA. , vol.104 , pp. 17783-17788
    • Rota, M.1    Kajstura, J.2    Hosoda, T.3
  • 17
    • 79955924124 scopus 로고    scopus 로고
    • Evidence for human lung stem cells
    • Kajstura J, Rota M, Hall SR, et al. Evidence for human lung stem cells. N Engl J Med. 2011;364:1795-1806.
    • (2011) N Engl J Med. , vol.364 , pp. 1795-1806
    • Kajstura, J.1    Rota, M.2    Hall, S.R.3
  • 22
    • 33846148701 scopus 로고    scopus 로고
    • Sorafenib in advanced clear-cell renal-cell carcinoma
    • TARGET Study Group
    • Escudier B, Eisen T, Stadler WM, et al; TARGET Study Group. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 2007;356:125-134.
    • (2007) N Engl J Med. , vol.356 , pp. 125-134
    • Escudier, B.1    Eisen, T.2    Stadler, W.M.3
  • 25
    • 23044510046 scopus 로고    scopus 로고
    • Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors
    • Clark JW, Eder JP, Ryan D, Lathia C, Lenz HJ. Safety and pharmacokinetics of the dual action Raf kinase and vascular endothelial growth factor receptor inhibitor, BAY 43-9006, in patients with advanced, refractory solid tumors. Clin Cancer Res. 2005;11:5472-5480.
    • (2005) Clin Cancer Res. , vol.11 , pp. 5472-5480
    • Clark, J.W.1    Eder, J.P.2    Ryan, D.3    Lathia, C.4    Lenz, H.J.5
  • 27
    • 27144527372 scopus 로고    scopus 로고
    • Phase i study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors
    • Moore M, Hirte HW, Siu L, Oza A, Hotte SJ, Petrenciuc O, Cihon F, Lathia C, Schwartz B. Phase I study to determine the safety and pharmacokinetics of the novel Raf kinase and VEGFR inhibitor BAY 43-9006, administered for 28 days on/7 days off in patients with advanced, refractory solid tumors. Ann Oncol. 2005;16:1688-1694.
    • (2005) Ann Oncol. , vol.16 , pp. 1688-1694
    • Moore, M.1    Hirte, H.W.2    Siu, L.3    Oza, A.4    Hotte, S.J.5    Petrenciuc, O.6    Cihon, F.7    Lathia, C.8    Schwartz, B.9
  • 29
    • 80054958413 scopus 로고    scopus 로고
    • Reversible cardiomyopathy associated with sunitinib and sorafenib
    • Uraizee I, Cheng S, Moslehi J. Reversible cardiomyopathy associated with sunitinib and sorafenib. N Engl J Med. 2011;365:1649-1650.
    • (2011) N Engl J Med. , vol.365 , pp. 1649-1650
    • Uraizee, I.1    Cheng, S.2    Moslehi, J.3
  • 30
    • 79959702678 scopus 로고    scopus 로고
    • Sorafenib-associated multivessel coronary artery vasospasm
    • Naib T, Steingart RM, Chen CL. Sorafenib-associated multivessel coronary artery vasospasm. Herz. 2011;36:348-351.
    • (2011) Herz. , vol.36 , pp. 348-351
    • Naib, T.1    Steingart, R.M.2    Chen, C.L.3
  • 33
    • 84861963722 scopus 로고    scopus 로고
    • Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib
    • Pantaleo MA, Mandrioli A, Saponara M, Nannini M, Erente G, Lolli C, Biasco G. Development of coronary artery stenosis in a patient with metastatic renal cell carcinoma treated with sorafenib. BMC Cancer 2012;12:231.
    • (2012) BMC Cancer , vol.12 , pp. 231
    • Pantaleo, M.A.1    Mandrioli, A.2    Saponara, M.3    Nannini, M.4    Erente, G.5    Lolli, C.6    Biasco, G.7
  • 34
    • 4944249117 scopus 로고    scopus 로고
    • BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis
    • Wilhelm SM, Carter C, Tang L, et al. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 2004;64:7099-7109.
    • (2004) Cancer Res. , vol.64 , pp. 7099-7109
    • Wilhelm, S.M.1    Carter, C.2    Tang, L.3
  • 35
    • 55749088393 scopus 로고    scopus 로고
    • Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
    • Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7:3129-3140.
    • (2008) Mol Cancer Ther. , vol.7 , pp. 3129-3140
    • Wilhelm, S.M.1    Adnane, L.2    Newell, P.3    Villanueva, A.4    Llovet, J.M.5    Lynch, M.6
  • 37
    • 33846212284 scopus 로고    scopus 로고
    • Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5
    • Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res. 2006;66:11851-11858.
    • (2006) Cancer Res. , vol.66 , pp. 11851-11858
    • Liu, L.1    Cao, Y.2    Chen, C.3    Zhang, X.4    McNabola, A.5    Wilkie, D.6    Wilhelm, S.7    Lynch, M.8    Carter, C.9
  • 41
    • 38049057402 scopus 로고    scopus 로고
    • Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model
    • Lin R, Peng H, Nguyen LP, Dudekula NB, Shardonofsky F, Knoll BJ, Parra S, Bond RA. Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model. Pulm Pharmacol Ther. 2008;21:115-124.
    • (2008) Pulm Pharmacol Ther. , vol.21 , pp. 115-124
    • Lin, R.1    Peng, H.2    Nguyen, L.P.3    Dudekula, N.B.4    Shardonofsky, F.5    Knoll, B.J.6    Parra, S.7    Bond, R.A.8
  • 42
    • 79251518319 scopus 로고    scopus 로고
    • Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade
    • Sorrentino SA, Doerries C, Manes C, et al. Nebivolol exerts beneficial effects on endothelial function, early endothelial progenitor cells, myocardial neovascularization, and left ventricular dysfunction early after myocardial infarction beyond conventional beta1-blockade. J Am Coll Cardiol. 2011;57:601-611.
    • (2011) J Am Coll Cardiol. , vol.57 , pp. 601-611
    • Sorrentino, S.A.1    Doerries, C.2    Manes, C.3
  • 43
    • 0027973061 scopus 로고
    • CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme
    • Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem. 1994;269:30761-30764.
    • (1994) J Biol Chem. , vol.269 , pp. 30761-30764
    • Fernandes-Alnemri, T.1    Litwack, G.2    Alnemri, E.S.3
  • 44
    • 84882759023 scopus 로고    scopus 로고
    • Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair
    • Ellison GM, Vicinanza C, Smith AJ, et al. Adult c-kit(pos) cardiac stem cells are necessary and sufficient for functional cardiac regeneration and repair. Cell 2013;154:827-842.
    • (2013) Cell , vol.154 , pp. 827-842
    • Ellison, G.M.1    Vicinanza, C.2    Smith, A.J.3
  • 45
    • 26244460357 scopus 로고    scopus 로고
    • Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival
    • Urbanek K, Rota M, Cascapera S, et al. Cardiac stem cells possess growth factor-receptor systems that after activation regenerate the infarcted myocardium, improving ventricular function and long-term survival. Circ Res. 2005;97:663-673.
    • (2005) Circ Res. , vol.97 , pp. 663-673
    • Urbanek, K.1    Rota, M.2    Cascapera, S.3
  • 46
    • 79957510296 scopus 로고    scopus 로고
    • Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells
    • Angert D, Berretta RM, Kubo H, Zhang H, Chen X, Wang W, Ogorek B, Barbe M, Houser SR. Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells. Circ Res. 2011;108:1226-1237.
    • (2011) Circ Res. , vol.108 , pp. 1226-1237
    • Angert, D.1    Berretta, R.M.2    Kubo, H.3    Zhang, H.4    Chen, X.5    Wang, W.6    Ogorek, B.7    Barbe, M.8    Houser, S.R.9
  • 49
    • 79953903083 scopus 로고    scopus 로고
    • Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair
    • Loffredo FS, Steinhauser ML, Gannon J, Lee RT. Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell 2011;8:389-398.
    • (2011) Cell Stem Cell , vol.8 , pp. 389-398
    • Loffredo, F.S.1    Steinhauser, M.L.2    Gannon, J.3    Lee, R.T.4
  • 53
    • 79954606808 scopus 로고    scopus 로고
    • Programmed necrosis, not apoptosis, in the heart
    • Kung G, Konstantinidis K, Kitsis RN. Programmed necrosis, not apoptosis, in the heart. Circ Res. 2011;108:1017-1036.
    • (2011) Circ Res. , vol.108 , pp. 1017-1036
    • Kung, G.1    Konstantinidis, K.2    Kitsis, R.N.3
  • 56
    • 33746207801 scopus 로고    scopus 로고
    • Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene
    • Rota M, LeCapitaine N, Hosoda T, et al. Diabetes promotes cardiac stem cell aging and heart failure, which are prevented by deletion of the p66shc gene. Circ Res. 2006;99:42-52.
    • (2006) Circ Res. , vol.99 , pp. 42-52
    • Rota, M.1    Lecapitaine, N.2    Hosoda, T.3
  • 57
    • 9644295769 scopus 로고    scopus 로고
    • Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis
    • Yamaguchi O, Watanabe T, Nishida K, et al. Cardiac-specific disruption of the c-raf-1 gene induces cardiac dysfunction and apoptosis. J Clin Invest. 2004;114:937-943.
    • (2004) J Clin Invest. , vol.114 , pp. 937-943
    • Yamaguchi, O.1    Watanabe, T.2    Nishida, K.3
  • 58
    • 33646149385 scopus 로고    scopus 로고
    • Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload
    • Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension. 2006;47:887-893.
    • (2006) Hypertension , vol.47 , pp. 887-893
    • Izumiya, Y.1    Shiojima, I.2    Sato, K.3    Sawyer, D.B.4    Colucci, W.S.5    Walsh, K.6
  • 59
    • 23644439061 scopus 로고    scopus 로고
    • Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
    • Shiojima I, Sato K, Izumiya Y, Schiekofer S, Ito M, Liao R, Colucci WS, Walsh K. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest. 2005;115:2108-2118.
    • (2005) J Clin Invest. , vol.115 , pp. 2108-2118
    • Shiojima, I.1    Sato, K.2    Izumiya, Y.3    Schiekofer, S.4    Ito, M.5    Liao, R.6    Colucci, W.S.7    Walsh, K.8
  • 60
    • 0025015293 scopus 로고
    • Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure
    • Katz AM. Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322:100-110.
    • (1990) N Engl J Med. , vol.322 , pp. 100-110
    • Katz, A.M.1
  • 61
    • 0032578406 scopus 로고    scopus 로고
    • Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the betaadrenergic pathway
    • Communal C, Singh K, Pimentel DR, Colucci WS. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the betaadrenergic pathway. Circulation 1998;98:1329-1334.
    • (1998) Circulation , vol.98 , pp. 1329-1334
    • Communal, C.1    Singh, K.2    Pimentel, D.R.3    Colucci, W.S.4
  • 63
    • 0035964246 scopus 로고    scopus 로고
    • Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance
    • Kubo H, Margulies KB, Piacentino V III, Gaughan JP, Houser SR. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 2001;104:1012-1018.
    • (2001) Circulation , vol.104 , pp. 1012-1018
    • Kubo, H.1    Margulies, K.B.2    Piacentino III, V.3    Gaughan, J.P.4    Houser, S.R.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.